Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

SCLC

September 24, 2021

First New Second-line Therapy for SCLC in Australia in 20 Years

By

Industry News & Regulatory Approvals

SEPTEMBER 14, 2021—Lurbinectedin received approval from the Therapeutic Goods Administration (TGA) as treatment for patients with metastatic SCLC who experienced disease progression during or after receipt of platinum-based chemotherapy. The […]
June 23, 2020

PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC

By

Meeting News

By Kara Nyberg, PhD Posted: June 24, 2020 The phase II PASSION trial sought to explore the potential synergy between immunotherapy and antiangiogenic drug therapy previously observed in preclinical studies. […]
November 11, 2019

2019 IASLC World Conference on Lung Cancer Updates

By

Meeting News

Posted: November 12, 2019 More than 7,700 delegates from around the world attended the IASLC 2019 World Conference on Lung Cancer (WCLC). With sessions and workshops on every aspect of […]